खोज परिणाम - Hirofumi Tamai
- प्रदर्शित 1 - 3 परिणाम 3
-
1
Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients द्वारा Yasuhiko Ito, Masashi Mizuno, Yasuhíro Suzuki, Hirofumi Tamai, Takeyuki Hiramatsu, Hiroshige Ohashi, Isao Ito, Hirotake Kasuga, Masanobu Horie, Shoichi Maruyama, Yukio Yuzawa, Tatsuaki Matsubara, Seiichi Matsuo
प्रकाशित 2013Artigo -
2
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study... द्वारा Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Kosaku Nitta, Tatsuo Tsukamoto, Shunya Uchida, Asami Takeda, Toshinobu Sato, Takashi Wada, Hiroki Hayashi, Yasuhiro Akai, Megumu Fukunaga, Kazuhiko Tsuruya, Kosuke Masutani, Tsuneo Konta, Tatsuya Shoji, Takeyuki Hiramatsu, Shunsuke Goto, Hirofumi Tamai, Saori Nishio, Arimasa Shirasaki, Kojiro Nagai, Kunihiro Yamagata, Hajime Hasegawa, Hideo Yasuda, Shizunori Ichida, Tomohiko Naruse, Tomoya Nishino, Hiroshi Sobajima, Satoshi Tanaka, Toshiyuki Akahori, Takafumi Ito, Yoshio Terada, Ritsuko Katafuchi, Shouichi Fujimoto, Hirokazu Okada, Eiji Ishimura, Junichiro James Kazama, Keiju Hiromura, Tetsushi Mimura, Satoshi Suzuki, Yosuke Saka, Tadashi Sofue, Yusuke Suzuki, Yugo Shibagaki, Kiyoki Kitagawa, Kunio Morozumi, Yoshiro Fujita, Makoto Mizutani, Takashi Shigematsu, Naoki Kashihara, Hiroshi Satō, Seiichi Matsuo, Ichiei Narita, Yoshitaka Isaka
प्रकाशित 2020Artigo -
3
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial द्वारा Kenjiro Kimura, Tatsuo Hosoya, Shunya Uchida, Masaaki Inaba, Hirofumi Makino, Shoichi Maruyama, Sadayoshi Ito, Tetsuya Yamamoto, Yasuhiko Tomino, Iwao Ohno, Yugo Shibagaki, Satoshi Iimuro, Naohiko Imai, Masanari Kuwabara, Hiroshi Hayakawa, Hiroshi Ohtsu, Yasuo Ohashi, Kenjiro Kimura, Tatsuo Hosoya, Sadayoshi Ito, Masaaki Inaba, Yasuhiko Tomino, Shunya Uchida, Hirofumi Makino, Seiichi Matsuo, Hisashi Yamanaka, Tetsuya Yamamoto, Iwao Ohno, Yugo Shibagaki, Satoshi Iimuro, Naohiko Imai, Masanari Kuwabara, Hiroshi Hayakawa, Tadao Akizawa, Tamio Teramoto, Hiroshi Kasanuki, Kenichi Yoshimura, Kenjiro Kimura, Tatsuo Hosoya, Yugo Shibagaki, Iwao Ohno, Hiroshi Sato, Shunya Uchida, Satoshi Horikoshi, Syoichi Maruyama, Masahiko Inaba, Yuji Moriwaki, Haruhito A. Uchida, Nagayuki Kaneshiro, Naohiko Imai, Hidekazu Moriya, Yasuhiro Komatsu, Shinya Kaname, K Hanaoka, Makoto Ogura, Masato Ikeda, Kenji Kasai, Akira Sugiura, Kazushi Takahashi, Kenichiro Kojima, Kosaku Nitta, Hirofumi Tamai, Hiroshi Nagaya, Senji Okuno, Ryusuke Kakiya, Hiroya Takeoka, Kyouji Hirata, Kenichiro Asano, Yasuo Fukaya, Yasushi Iwaida, Y Tsuneda, Shigeaki Nishimura, Takeyuki Hiramatsu, Yoshitaka Isaka, Takafumi Ito, Yukio Yuzawa, Kunihiro Yamagata, Tadashi Sofue, Yoshimi Jinguji, Keita Hirano, Kazuhiro Matsuyama, Teruhiko Mizumoto, Yuko Shibuya, Masahiro SUGAWARA, Moritoshi Kadomura, Yasuaki Teshima, Hiroshi Ohtani, Hiroki Kamata, Okawara Susumu, M. Fukushima, Katsumi Takemura, Eriko Kinugasa, Masami Kogure, Y. Ehara
प्रकाशित 2018Artigo
खोज साधन:
संबंधित विषय
Internal medicine
Medicine
Kidney
Kidney disease
Proteinuria
Randomized controlled trial
Renal function
Urology
Adverse effect
Aldosterone
Alternative medicine
Asymptomatic
Biology
Blood pressure
Cardiology
Clinical endpoint
Cohort
Creatinine
Dialysis
Disease
Ejection fraction
End stage renal disease
Febuxostat
Gastroenterology
Heart failure
Hyperkalemia
Hyperuricemia
Incidence (geometry)
Left ventricular hypertrophy
Mineralocorticoid receptor